How Mochi Health Compares to the Standard of Care The American Association of Clinical Endocrinology (AACE) 2023 obesity management algorithm recommends that patients with BMI 30 (or BMI 27 with at least one obesity-related comorbidity) be offered pharmacotherapy alongside lifestyle intervention, with prescriber follow-up at 4, 8, and 12 weeks after initiation, then every 3 months [13]
While this was initially thought to cause health problems, new studies suggest that isnt the case
This expanding therapeutic landscape is also influenced by evolving treatment pathways in major global markets, including the United States, China, India, and Germany, which are strengthening obesity- and diabetes-care frameworks
The trade-off is extra complexity
Fumaric acid, bound to L-carnitine, also occurs naturally as an intermediate product in the citric acid cycle
Adults experiencing hormonal decline symptoms such as fatigue, poor sleep, or muscle loss may benefit